Redmond Regional Medical Middle is now presenting Bamlanivimab antibody infusions to non-hospitalized individuals who have tested beneficial for COVD-19 and have other substantial-possibility variables.
The U.S. Foods and Drug Administration granted Emergency Use Authorization of Bamlanivimab for the treatment of COVID-19 in clients enduring gentle to reasonable indications who are significant-chance to acquire critical COVID-19. The drug is administered by outpatient IV infusion for grownups and adolescents age 12 and more mature.
High-chance circumstances that may well be eligible for this treatment incorporate:
♦ Serious Kidney Illness
♦ Immunosuppressive Ailment
For kids about the age of 12, sickle mobile ailment, neurodevelopmental conditions and bronchial asthma are also between quite a few added things to consider for eligibility.
Medication offer is restricted and administered based on availability. Patients ought to have a health practitioner referral and satisfy eligibility prerequisites to be regarded for the treatment. The outpatient infusion is provided around the program of one particular hour, followed by an supplemental hour of observation.
Bamlanivimab is not licensed for sufferers who:
♦ Are hospitalized due to COVID-19
♦ Call for oxygen therapy because of to COVID-19
♦ Call for oxygen thanks to yet another underlying medical ailment
Redmond Regional Medical Center is presenting treatment appointments on Mondays from 12:00 p.m. to 7:00 p.m. and on Wednesdays and Fridays from 9:00 a.m. to 4:00 p.m.
If you have recently tested beneficial for COVID-19 and are intrigued in this treatment, you should access out to your most important care physician for a referral to Redmond’s Outpatient Bamlanivimab Clinic.